Columbia Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Columbia Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,649	Closed	-$355K	–	185
2016 Q1	$355K	Buy	6,649 +599	+10%	+$35.1K	0.13%	131
2015 Q4	$397K	Buy	6,050 +2,110	+54%	+$130K	0.16%	114
2015 Q3	$222K	Hold	3,940	–	–	0.09%	157
2015 Q2	$232K	Sell	3,940 -200	-5%	-$12.3K	0.09%	170
2015 Q1	$258K	Hold	4,140	–	–	0.1%	167
2014 Q4	$238K	Sell	4,140 -525	-11%	-$29.2K	0.09%	166
2014 Q3	$251K	Hold	4,665	–	–	0.1%	159
2014 Q2	$245K	Hold	4,665	–	–	0.1%	163
2014 Q1	$246K	Sell	4,665 -650	-12%	-$30K	0.11%	155
2013 Q4	$213K	Buy	+5,315	New	+$209K	0.09%	159

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Columbia Asset Management's TEVA Position: Q2 2016 in Review

Columbia Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2016, closing a stake of 6,649 shares — an estimated $355K sold.

Columbia Asset Management first reported a position in TEVA in Q4 2013 and held it in 10 quarters. The position peaked at $397K in Q4 2015. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Columbia Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2016 after selling out during the quarter.
Columbia Asset Management sold 6,649 Teva Pharmaceutical Industries Limited shares in Q2 2016, an estimated $355K.
Columbia Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 10 quarters.
Columbia Asset Management's Teva Pharmaceutical Industries Limited position peaked at $397K in Q4 2015.
813 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2016.

Based on Columbia Asset Management's 13F filing for Q2 2016, filed 8 Aug 2016.